Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033878 · ClinicalTrials.gov registry record · Phase 1
Study of Noni in Cancer Patients
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00033878: Completed Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00033878 is a Phase 1 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00033878, a Phase 1 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this Phase 1 study is to: 1. determine the maximum tolerated dose of capsules containing 500mg of freeze dried noni fruit extract, 2. define toxicities associated with the ingestion of noni, 3. collect preliminary information on the efficacy of noni in respect to anti-tumor and symptom control properties to help select specific patients for subsequent Phase 2 studies, 4. identify chemical constituents of the extract that can be used to characterize the bioavailability and pharmacokinetics of noni food supplement.
Interventions
- DRUG Noni Extract
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-11 |
| Est. Completion | 2006-06 |
| Phase | Phase 1 |
What the finished NCT00033878 record still lists
NCT00033878 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Noni Extract is the first listed.
NCT00033878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00033878 about?
NCT00033878 is a clinical study titled "Study of Noni in Cancer Patients". The purpose of this Phase 1 study is to: 1. determine the maximum tolerated dose of capsules containing 500mg of freeze dried noni fruit extract, 2. define toxicities associated with the ingestion of noni, 3. collect preliminary information on the efficacy of noni in respect to anti-tumor and sympto...
What is the current status of trial NCT00033878?
This trial is currently completed. It is a Phase 1 study. The study started on 2001-11. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00033878?
The interventions under investigation include: Noni Extract (DRUG).
Who is sponsoring clinical trial NCT00033878?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia